Shir Lynn Lim
Singapore
Dr Shir Lynn Lim is a Senior Consultant Cardiologist at the National University Heart Centre Singapore and holds appointments with the Yong Loo Lin School of Medicine and Duke-NUS Medical School. She leads the national In-Hospital Cardiac Arrest Workgroup and is a member of the National Post-Cardiac Arrest and Survivorship Workgroup as well as Pan-Asian Resuscitation Outcomes Study. She is the founding Director of the Clinical Trials Unit of NUHCS and the inaugural lead of the Early Phase Mechanistic Clinical Trials Platform of the CArdiovascular DiseasE National Collaborative Enterprise (CADENCE), a national clinical translational program set up in February 2023 which aims to synergize cardiovascular research and technology capabilities across Singapore. She is also an Associate Editor of Resuscitation.
Aligned with her clinical subspecialty of critical care cardiology, her research is focused on acute cardiac conditions such as cardiorenal syndrome, cardiac arrest and cardiogenic shock. Her overarching goal as a clinician-scientist is to improve the long-term outcomes of critically ill cardiac patients through the use of biomarkers and mechanistic early phase clinical trials during the acute phase, as well as the use of novel strategies, knowledge translation and clinical implementation in improving survivorship.
